William F. Matter

5.2k total citations · 2 hit papers
19 papers, 4.5k citations indexed

About

William F. Matter is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, William F. Matter has authored 19 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Immunology and 3 papers in Surgery. Recurrent topics in William F. Matter's work include Protein Kinase Regulation and GTPase Signaling (6 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and Cellular transport and secretion (2 papers). William F. Matter is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (6 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and Cellular transport and secretion (2 papers). William F. Matter collaborates with scholars based in United States and United Kingdom. William F. Matter's co-authors include Chris J. Vlahos, Raymond F. Brown, K. Y. Hui, Jeffrey A. Dodge, Alfred Gallegos, Robert T. Abraham, Leon H. Zalkow, Gerald B. Grindey, Rosanne Bonjouklian and Garth Powis and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

William F. Matter

19 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).

1994 2.9k citations Chris J. Vlahos, William F. Matter et al. Journal of Biological Chemistry profile →
Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.

1994 611 citations Garth Powis, Rosanne Bonjouklian et al. PubMed profile →

Peers

Countries citing papers authored by William F. Matter

Since Specialization

Citations

This map shows the geographic impact of William F. Matter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William F. Matter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William F. Matter more than expected).

Fields of papers citing papers by William F. Matter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William F. Matter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William F. Matter. The network helps show where William F. Matter may publish in the future.

Co-authorship network of co-authors of William F. Matter

This figure shows the co-authorship network connecting the top 25 collaborators of William F. Matter. A scholar is included among the top collaborators of William F. Matter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William F. Matter. William F. Matter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Effects of pharmacological inhibition of the sodium‐dependent phosphate cotransporter 2b (NPT2b) on intestinal phosphate absorption in mouse and rat models 2022 ·Pharmacology Research & Perspectives ·Xiaojun Wang, Yanping Xu, (unknown), Asim Dey, Hong Y. Zhang, (unknown), (unknown), (unknown), William F. Matter, (unknown), Charles A. Reidy, Jeffrey A. Peterson, Brian Mattioni, Joseph V. Haas, Mark C. Kowala, John R. Wetterau	4
2	The Angiopoietin-Like Protein 3 and 8 Complex Interacts with Lipoprotein Lipase and Induces LPL Cleavage 2021 ·ACS Chemical Biology ·Najia Jin, William F. Matter, Laura F. Michael, Yuewei Qian, T. Gheyi, (unknown), Carlos A. Perez, (unknown), Howard B. Broughton, Alfonso Espada	26
3	ESR and X-ray Structure Investigations on the Binding and Mechanism of Inhibition of the Native State of Myeloperoxidase with Low Molecular Weight Fragments 2015 ·Applied Magnetic Resonance ·C. Balagopalakrishna, Thierry Masquelin, Mark J. Nilges, David E. Timm, Stephanie L. Stout, William F. Matter, Najia Jin, Prabhakar K. Jadhav, Gary G. Deng	2
4	Discovery of Cathepsin S Inhibitor LY3000328 for the Treatment of Abdominal Aortic Aneurysm 2014 ·ACS Medicinal Chemistry Letters ·Prabhakar K. Jadhav, (unknown), (unknown), (unknown), Donald P. Matthews, Michael A. Staszak, Donald S. Coffey, (unknown), Kenneth C. Cassidy, Richard A. Brier, Yuke Zhang, Robert Christie, William F. Matter, Keyun Qing, Jim D. Durbin, Yong Wang, Gary G. Deng	50
5	Solenopsin, the alkaloidal component of the fire ant (Solenopsis invicta), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesis 2006 ·Blood ·Jack L. Arbiser, (unknown), (unknown), Krishna K. Narra, Ramani Ramchandran, Scott A. Summers, Chris J. Vlahos, Keqiang Ye, Betsy N. Perry, William F. Matter, Anthony S. Fischl, James A. Cook, Pamela A. Silver, Jenny Bain, Philip Cohen, (unknown), (unknown), Baskaran Govindarajan, J. Phillip Bowen	85
6	Complete Inhibition of Anisomycin and UV Radiation but Not Cytokine Induced JNK and p38 Activation by an Aryl-substituted Dihydropyrrolopyrazole Quinoline and Mixed Lineage Kinase 7 Small Interfering RNA 2005 ·Journal of Biological Chemistry ·Xushan Wang, Mary M. Mader, John E. Toth, (unknown), Najia Jin, Robert M. Campbell, Jeffrey K. Smallwood, Michael E. Christe, Arindam Chatterjee, Theodore Goodson, Chris J. Vlahos, William F. Matter, Laura J. Bloem	69
7	Effect of drotrecogin alfa (activated) on human endothelial cell permeability and Rho kinase signaling 2004 ·Critical Care Medicine ·Wei Zeng, William F. Matter, S. Betty Yan, Suzane L. Um, Chris J. Vlahos, (unknown)	41
8	A cell-based immunocytochemical assay for monitoring kinase signaling pathways and drug efficacy 2004 ·Analytical Biochemistry ·Huaxian Chen, Joy L. Kovar, Sean E. Sissons, Karen L. Cox, William F. Matter, (unknown), Peng Luan, Chris J. Vlahos, Amy Schutz‐Geschwender, D. Michael Olive	66
9	Phosphoinositide 3-kinase regulates excitation-contraction coupling in neonatal cardiomyocytes 2004 ·American Journal of Physiology-Heart and Circulatory Physiology ·Susan A. McDowell, Eileen McCall, William F. Matter, Thomas Estridge, Chris J. Vlahos	18
10	Role of PRL-3, a Human Muscle-Specific Tyrosine Phosphatase, in Angiotensin-II Signaling 2001 ·Biochemical and Biophysical Research Communications ·William F. Matter, Thomas Estridge, Chen Zhang, Rama M. Belagaje, Louis F. Stancato, S. Jeffrey Dixon, Brian N. Johnson, Laura J. Bloem, (unknown), (unknown), Susan Acton, Raju Jeyaseelan, Vivek J. Kadambi, Chris J. Vlahos	115
11	Calmodulin Activates Phosphatidylinositol 3-Kinase 1997 ·Journal of Biological Chemistry ·John L. Joyal, Deborah J. Burks, Sebastián Pons, William F. Matter, Chris J. Vlahos, Morris F. White, David B. Sacks	145
12	Effects of wortmannin analogs on bone in vitro and in vivo. 1996 ·Journal of Pharmacology and Experimental Therapeutics ·Masahiko Sato, H.U. Bryant, Jeffrey A. Dodge, Harmon H. Davis, William F. Matter, Chris J. Vlahos	9
13	LY295427, a novel hypocholesterolemic agent, enhances [3H]25-hydroxycholesterol binding to liver cytosolic proteins 1996 ·Journal of Lipid Research ·Nancy Bowling, William F. Matter, Robert A. Gadski, (unknown), (unknown), Paul A. Dawson, Chris J. Vlahos	9
14	Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase. 1995 ·The Journal of Immunology ·Chris J. Vlahos, William F. Matter, Raymond F. Brown, Alexis Traynor‐Kaplan, P G Heyworth, Eric R. Prossnitz, R D Ye, Philip Marder, (unknown), (unknown), (unknown), (unknown)	162
15	17β-hydroxywortmannin: A potent inhibitor of bone resorption and phosphatidylinositol-3-kinase 1995 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey A. Dodge, Henry U. Bryant, John Kim, William F. Matter, Bryan H. Norman, Usha Srinivasan, Chris J. Vlahos, Masahiko Sato	11
16	A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). breakdown → 1994 ·Journal of Biological Chemistry ·Chris J. Vlahos, William F. Matter, K. Y. Hui, Raymond F. Brown	2905
17	Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. breakdown → 1994 ·PubMed ·Garth Powis, Rosanne Bonjouklian, Margareta Berggren, Alfred Gallegos, Robert T. Abraham, Curtis L. Ashendel, Leon H. Zalkow, William F. Matter, Jeffrey A. Dodge, Gerald B. Grindey	611
18	Signal transduction in neutrophil activation Phosphatidylinositol 3‐kinase is stimulated without tyrosine phosphorylation 1992 ·FEBS Letters ·Chris J. Vlahos, William F. Matter	52
19	The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs 1992 ·Biochemical and Biophysical Research Communications ·William F. Matter, Raymond F. Brown, Chris J. Vlahos	166

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact